Perspective: How will healthcare reform affect cancer care?

Article

In this video interview, Oncology board member and CancerNetwork contributing editor, Derek Raghavan, MD, PhD, Institute Chair, Taussig Cancer Institute gives his opinion on how the changing landscape of the American healthcare system will affect cancer care.

In this video interview, Oncology board member and CancerNetwork contributing editor, Derek Raghavan, M.D., Ph.D, Institute Chair, Taussig Cancer Institute gives his opinion on how the changing landscape of the American healthcare system will affect cancer care.

Interview: news.cancerconnect.com/asco-2010-how-will-healthcare-reform-affect-cancer-care/

Perspectives and concerns about the affects of Obama-care abound…

On July, 14th the Community Oncology Alliance (COA) announced that due to severe year after year cuts to Medicare reimbursement for cancer care, community oncologists around the US are closing offices at a rate rapidly increasing since January 2010. Reductions in staff, services and facilities are also on the rise.

“As a practicing oncologist, I am extremely concerned about the impact these closings have on
patients. Many are simply falling through the cracks as providers are being forced to cut staff and
close clinics, forcing patients to seek treatments outside of their communities,” said David Eagle,
MD, newly elected President of COA.

--Look here for continuing coverage and analysis of the policies coming from Capitol Hill that directly impact the delivery of oncology services across the country.

 

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content